Heterogeneity and phenotypic stratification in acute respiratory distress syndrome

Affiliations

¹ Peter Munk Cardiac Centre, Toronto General Hospital, Toronto, ON M5G 2C4, Canada; Heart and Stroke/Richard Lewar Centre of Excellence, University of Toronto, Toronto, ON, Canada; Interdepartmental Division of Critical Care Medicine, University of Toronto, ON, Canada; Department of Medicine, University Health Network and Sinai Health System, Toronto, ON, Canada; Department of Medicine, University of Toronto, Toronto, ON, Canada.
² Department of Medicine, University of Toronto, Toronto, ON, Canada; Institute of Health Policy, Management and Evaluation, University of Toronto, ON, Canada. Electronic address: eddy.fan@uhn.ca.

Comment

Patrick R Lawler et al. Lancet Respir Med. 2018 Sep.

. 2018 Sep;6(9):651-653.

doi: 10.1016/S2213-2600(18)30287-X. Epub 2018 Aug 2.

¹ Peter Munk Cardiac Centre, Toronto General Hospital, Toronto, ON M5G 2C4, Canada; Heart and Stroke/Richard Lewar Centre of Excellence, University of Toronto, Toronto, ON, Canada; Interdepartmental Division of Critical Care Medicine, University of Toronto, ON, Canada; Department of Medicine, University Health Network and Sinai Health System, Toronto, ON, Canada; Department of Medicine, University of Toronto, Toronto, ON, Canada.
² Department of Medicine, University of Toronto, Toronto, ON, Canada; Institute of Health Policy, Management and Evaluation, University of Toronto, ON, Canada. Electronic address: eddy.fan@uhn.ca.

No abstract available

Comment on

Acute respiratory distress syndrome subphenotypes and differential response to simvastatin: secondary analysis of a randomised controlled trial.
Calfee CS, Delucchi KL, Sinha P, Matthay MA, Hackett J, Shankar-Hari M, McDowell C, Laffey JG, O'Kane CM, McAuley DF; Irish Critical Care Trials Group. Calfee CS, et al. Lancet Respir Med. 2018 Sep;6(9):691-698. doi: 10.1016/S2213-2600(18)30177-2. Epub 2018 Aug 2. Lancet Respir Med. 2018. PMID: 30078618 Free PMC article. Clinical Trial.